AMN vs. AMED, MD, CCRN, LH, DGX, DVA, CHE, CRVL, NSP, and ASGN
Should you be buying AMN Healthcare Services stock or one of its competitors? The main competitors of AMN Healthcare Services include Amedisys (AMED), Pediatrix Medical Group (MD), Cross Country Healthcare (CCRN), Laboratory Co. of America (LH), Quest Diagnostics (DGX), DaVita (DVA), Chemed (CHE), CorVel (CRVL), Insperity (NSP), and ASGN (ASGN).
AMN Healthcare Services vs.
Amedisys (NASDAQ:AMED) and AMN Healthcare Services (NYSE:AMN) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their earnings, risk, dividends, media sentiment, analyst recommendations, profitability, community ranking, institutional ownership and valuation.
Amedisys currently has a consensus price target of $100.75, indicating a potential upside of 9.51%. AMN Healthcare Services has a consensus price target of $41.17, indicating a potential upside of 67.41%. Given AMN Healthcare Services' stronger consensus rating and higher possible upside, analysts plainly believe AMN Healthcare Services is more favorable than Amedisys.
In the previous week, Amedisys had 8 more articles in the media than AMN Healthcare Services. MarketBeat recorded 18 mentions for Amedisys and 10 mentions for AMN Healthcare Services. Amedisys' average media sentiment score of 0.05 beat AMN Healthcare Services' score of -0.11 indicating that Amedisys is being referred to more favorably in the media.
94.4% of Amedisys shares are owned by institutional investors. Comparatively, 99.2% of AMN Healthcare Services shares are owned by institutional investors. 2.1% of Amedisys shares are owned by company insiders. Comparatively, 0.9% of AMN Healthcare Services shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.
Amedisys has higher earnings, but lower revenue than AMN Healthcare Services. AMN Healthcare Services is trading at a lower price-to-earnings ratio than Amedisys, indicating that it is currently the more affordable of the two stocks.
Amedisys has a beta of 0.73, suggesting that its share price is 27% less volatile than the S&P 500. Comparatively, AMN Healthcare Services has a beta of 0.07, suggesting that its share price is 93% less volatile than the S&P 500.
Amedisys received 47 more outperform votes than AMN Healthcare Services when rated by MarketBeat users. However, 68.61% of users gave AMN Healthcare Services an outperform vote while only 58.65% of users gave Amedisys an outperform vote.
Amedisys has a net margin of 3.57% compared to AMN Healthcare Services' net margin of -4.93%. AMN Healthcare Services' return on equity of 15.22% beat Amedisys' return on equity.
Summary
Amedisys beats AMN Healthcare Services on 11 of the 18 factors compared between the two stocks.
Get AMN Healthcare Services News Delivered to You Automatically
Sign up to receive the latest news and ratings for AMN and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
AMN Healthcare Services Competitors List
Related Companies and Tools
This page (NYSE:AMN) was last updated on 3/4/2025 by MarketBeat.com Staff
